Association between HLA class H genotype and spontaneous clearance of hepatitis C viraemia

Journal of Hepatology

Volumn 29, Issue 2, 1998, Pages 207-213

  Cramp, Matthew E ^a   Carucci, Patrizia ^a   Underhill, James ^a   Naoumov, Nikolai V ^b   Williams, Roger ^b   Donaldson, Peter T ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

DQB1(*)0301; Hepatitis C virus; HLA; MHC class II; Viral clearance

Indexed keywords

HEPATITIS C ANTIBODY; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN; VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC HEPATITIS; CLEARANCE; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIREMIA;

EID: 0032146913     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80005-6     Document Type: Article

References (19)

1. van der Poel CL, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet. 344:1994;1475-1479.
2. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic Non-A, Non-B Hepatitis Study Team. N Engl J Med. 327:1992;1899-1905.
3. Tong ML, et al., Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis. N Engl J Med. 332:1995;1436-1446.
4. Dusheiko G, Schmilovitz Weiss H, Brown D, McOmish F, Yap PL, et al. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology. 19:1994;13-18.
5. Diepoler HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, et al. Possible mechanisms involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet. 346:1995;1006-1007.
6. Cramp ME, Carucci P, Chokshi S, Rossol S, Donaldson PT, Williams R, et al. A multispecific T lymphocyte response to hepatitis C virus proteins occurs in patients with viral clearance and persists many years after exposure [abstract]. Hepatology. 24:1996;252.
7. Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, Hill AV. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med. 332:1995;1065-1069.
8. Steel CM, Ludlam CA, Beatson D, Peutherer JF, Cuthbert RJ, Simmonds P, et al. HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease. Lancet. i:1988;1185-1188.
9. Tibbs C, Donaldson P, Underhill J, Thomson L, Manabe K, Williams R. Evidence that the HLA DQA1*03 allele confers protection from chronic HCV-infection in Northern European Caucasoids. Hepatology. 24:1996;1340-1345.
10. Peano G, Menardi G, Ponzetto A, Fenoglio LM. HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection? Arch Intern Med. 154:1994;2733-2736.
11. Aikawa T, Kojima M, Onishi H, Tamura R, Fukuda S, Suzuki T, et al. HLA DRB1 and DQB1 alleles and haplotypes influencing the progression of hepatitis C. J Med Virol. 49:1996;274-278.
12. Kuzushita N, Hayashi N, Moribe T, Katayama K, Kanto T, Nakatani S, et al. Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus. Hepatology. 27:1998;240-244.
13. Alric L, Fort M, Izopet J, Vinel J-P, Charlet J-P, Selves J, et al. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology. 113:1997;1675-1681.
14. Gerken G, Pontisso P, Roggenorf M, Rumi MG, Simmonds P, Trepo C, et al. Clinical evaluation of a single reaction, diagnostic polymerase chain reaction assay for detection of hepatitis C virus RNA. J Hepatol. 24:1996;33-37.
15. Kimura S, Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. Tsuji K, Aizawa M. Proceedings of the Eleventh Interational Histocompatibility Workshop and Conference, Yokohama, Japan, 1991. 1991;397-419 Oxford University Press, Oxford.
16. Svejgaard A, Ryder LP. HLA and disease associations: detecting the strongest association. Tissue Antigens. 43:1994;18-27.
17. Zavaglia C, Bortolon C, Ferrioli G, Rho A, Mondazzi L, Bottelli R, et al. HLA typing in chronic type B, D and C hepatitis. J Hepatol. 24:1996;658-665.
18. Kuzushita N, Hayashi N, Katayama K, Hiramatsu N, Yasumaru M, Murata H, et al. Increased frequency of HLA DR13 in hepatitis C virus carriers with persistently normal ALT levels. J Med Virol. 48:1996;1-7.
19. Bernal W, Cramp ME, Underhill JA, Carucci P, Donaldson PT. Tumour necrosis factor gene polymorphisms in hepatitis C virus infection [abstract]. Hepatology. 26:1997;482.